No trial has tested ipamorelin in women. The human data are one small 1999 study in 40 healthy men and one 2014 trial in bowel-surgery patients. Everything you read about fat loss, skin or sleep in women comes from the mechanism, rat studies and user reports.
That is the short answer. The rest of this page shows what each study did, what it left out, and what to ask before you consider it.
In animals
Ipamorelin released growth hormone in rats and pigs, and grew bones in female rats.
In people
One dose study in 40 men and one surgery trial that did not beat placebo.
In women
No trial exists for fat loss, sleep, skin or menopause.
What is ipamorelin and how does it work?
Ipamorelin is a five-amino-acid peptide that binds the ghrelin receptor and makes the pituitary release growth hormone (GH). GH then raises IGF-1, a hormone made mostly in the liver.
Researchers at Novo Nordisk described it in a 1998 paper as the first selective GH secretagogue. In swine, older drugs of this class (GHRP-2 and GHRP-6) raised ACTH and cortisol. Ipamorelin did not, even at doses more than 200 times the dose that releases GH. It also left FSH, LH, prolactin and TSH alone in those pigs.
That is where the “clean” reputation comes from. It is pig data in a single paper. It says nothing about women’s cycles, because estrogen and progesterone were not measured and no woman took part.
What do the studies show?
| Study | Who | What it found | Limit |
|---|---|---|---|
| Raun 1998 | Rats and swine | GH release without a rise in ACTH or cortisol | No humans |
| Gobburu 1999 | 40 healthy men, 8 per dose | One 15-minute infusion raised GH at every dose | Single dose, men only |
| Svensson 2000 | Adult female rats, 12 weeks | Bone mineral content rose because bones grew larger | Rats. Density per volume did not change |
| Beck 2014 | 117 bowel-surgery patients, 114 analyzed | Well tolerated. Time to first meal 25.3 vs 32.6 hours, p = 0.15 | Not better than placebo. Surgery patients, up to 7 days |
Read that table as a short list of what is known. A review in Frontiers in Endocrinology from 2026 sorts these peptides by evidence tier and highlights the uncertainty around recomposition benefits.
Does ipamorelin work for fat loss, sleep, skin or energy?
Nobody has tested it. These are the claims you see most, and what exists for each.
| Claim | Human trial in women? | What backs it |
|---|---|---|
| Fat loss | None | GH breaks down fat in general. Ipamorelin was never tested for it |
| Better sleep | None | User reports |
| Firmer skin and hair | None | IGF-1 acts on collagen cells in the lab |
| More energy | None | User reports |
| Muscle tone | None | GH builds protein, but no ipamorelin trial measured muscle |
| Faster recovery | None | A 2026 sports medicine review found the claimed benefits unsubstantiated by human trials |
Online posts give timelines like “sleep in two weeks, fat loss by week 12.” No study produced those numbers. They are marketing or one person’s story.
What about bone density and menopause?
Bone is the one area with a female study, and it was in rats. In the 2000 study the rats grew bigger bones, so total bone mineral rose. Density per volume did not change. No human has tested ipamorelin for bone, so it is not a plan for osteoporosis.
Menopause works the same way. No trial has tested ipamorelin for hot flashes, sleep or belly fat after menopause. It does not replace estrogen. If you are on hormone therapy, a doctor who knows both your protocol and any peptide you take is the only person who can check for problems.
What are the side effects?
Nobody has measured them in women. The 2014 surgery trial reported adverse events in 87.5% of the ipamorelin group and 94.8% of the placebo group, and those patients were sick, so it tells you little about healthy people.
For the drug class, the 2026 review lists these reported effects:
- Injection-site reactions
- Fluid retention
- Muscle and joint pain
- Appetite changes
- Blood sugar changes
Long-term data do not exist. The longest human exposure in the studies above was seven days.
Who should not take ipamorelin?
- Active cancer or recent treatment: IGF-1 can feed cell growth. The mitogenic risk is unproven, and nobody has ruled it out.
- Cancer history, especially hormone-sensitive: talk to your oncologist first.
- Pregnant, breastfeeding or trying to conceive: there are no safety data, so skip it.
- Diabetes or blood sugar problems: GH affects glucose, and the class has been linked to dysglycemia.
- Heart, kidney or liver disease: ask the doctor who treats it.
How does ipamorelin compare with other options?
| Ipamorelin | Sermorelin | Tesamorelin | MK-677 (oral) | |
|---|---|---|---|---|
| How it works | Ghrelin receptor | GHRH receptor | GHRH analog | Ghrelin receptor, oral |
| FDA status | Not approved | Once approved, no longer sold | Approved for belly fat in HIV lipodystrophy | Not approved |
| Best evidence | GH release in men | Older GH-testing use | Randomized trials on visceral fat | Raises GH and IGF-1 |
| Known concern | No human efficacy data | Little current data | Cost, prescription only | Blood sugar and heart failure signals |
If belly fat is your goal, tesamorelin is the only one in this table with a regulatory approval for a fat indication, and it is a prescription drug for a specific group. Ipamorelin has no such approval.
Is ipamorelin legal?
Ipamorelin is not FDA-approved for any use. The FDA places ipamorelin acetate in Category 2 of its bulk drug substances list, which it reserves for substances that may carry significant safety risks. It is not one of the peptides covered by the HHS enforcement policy announced on 28 October 2026.
Vials sold online as “research chemicals” are not meant for human use. WADA also bans ipamorelin at all times under S2.2.4, so athletes in tested sports should avoid it.
How do you check a vial before you buy?
1. Ask for a certificate of analysis from an independent lab.
2. Match the lot number on the certificate to your vial.
3. Check that the lab is real and the report is not an edited image.
4. Compare sellers in our vendor investigations.
For the wider picture on peptides and women, read our guide to peptides for women.
Questions
Is ipamorelin safe for women?
Nobody knows. No trial has tested it in women, and long-term safety data do not exist.
Does ipamorelin affect your period or hormones?
No study has checked. The 1998 pig study found no change in FSH, LH, prolactin or TSH, but it did not measure estrogen or progesterone.
Will ipamorelin cause weight loss?
No trial has measured it. The only fat-loss claims come from user reports.
Can you take ipamorelin with HRT or birth control?
No interaction study exists. Ask a doctor who sees your full medication list.
How long does ipamorelin take to work?
There is no tested timeline. Any number online comes from user reports.
Is ipamorelin the same as CJC-1295?
No. Ipamorelin acts on the ghrelin receptor. CJC-1295 is a GHRH analog and works through a different receptor.
Can you take ipamorelin while pregnant?
No. There are no safety data for pregnancy or breastfeeding.